<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Florida_Atlantic_HP_Silver skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Florida Atlantic/HP/Silver</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="igem_2017_menu_wrapper"><DIV class="menu_button" id="display_menu_control">
		MENU  
	</DIV><DIV id="menu_content"><A href="https://2017.igem.org/Team:Florida_Atlantic"><DIV class="menu_button direct_to_page">
				HOME
			</DIV></A><DIV class="menu_button"> TEAM 
		</DIV><DIV class="submenu_wrapper" id="team_submenu"><A href="https://2017.igem.org/Team:Florida_Atlantic/Team"><DIV class="submenu_button" id="Team_page">
					Team 
				</DIV></A><A href="https://2017.igem.org/Team:Florida_Atlantic/Acknowledgements"><DIV class="submenu_button" id="Acknowledgements_page">
					Acknowledgements
				</DIV></A></DIV><DIV class="menu_button"> PROJECT
		</DIV><DIV class="submenu_wrapper"><A href="https://2017.igem.org/Team:Florida_Atlantic/Description"><DIV class="submenu_button" id="Description_page">		Description
				</DIV></A><A href="https://2017.igem.org/Team:Florida_Atlantic/Design"><DIV class="submenu_button" id="Design_page">
					Design
				</DIV></A><A href="https://2017.igem.org/Team:Florida_Atlantic/Experiments"><DIV class="submenu_button" id="Experiments_page">
					Experiments
				</DIV></A><A href="https://2017.igem.org/Team:Florida_Atlantic/InterLab"><DIV class="submenu_button" id="InterLab_page">
					InterLab
				</DIV></A><A href="https://2017.igem.org/Team:Florida_Atlantic/Model"><DIV class="submenu_button" id="Model_page">
					Model
				</DIV></A><A href="https://2017.igem.org/Team:Florida_Atlantic/Results"><DIV class="submenu_button" id="Results_page">
					Results
				</DIV></A><A href="https://2017.igem.org/Team:Florida_Atlantic/Attributions"><DIV class="submenu_button" id="Attributions_page">
					Attributions 
				</DIV></A><A href="https://2017.igem.org/Team:Florida_Atlantic/Pictures"><DIV class="submenu_button" id="Pictures_page">
					Pictures
				</DIV></A></DIV><DIV class="menu_button"> HUMAN PRACTICES 
		</DIV><DIV class="submenu_wrapper"><A href="https://2017.igem.org/Team:Florida_Atlantic/HP/Silver"><DIV class="submenu_button" id="Silver_page">
					Silver HP
				</DIV></A><A href="https://2017.igem.org/Team:Florida_Atlantic/HP/Gold"><DIV class="submenu_button" id="Gold_page">
					Gold HP
				</DIV></A></DIV><DIV class="menu_button"> AWARDS
		</DIV><DIV class="submenu_wrapper"><A href="https://2017.igem.org/Team:Florida_Atlantic/Model"><DIV class="submenu_button" id="Model_page">
					Model
				</DIV></A><A href="https://2017.igem.org/Team:Florida_Atlantic/Software"><DIV class="submenu_button" id="Software_page">
					Software
				</DIV></A></DIV><A href="https://2017.igem.org/Team:Florida_Atlantic/Safety"><DIV class="menu_button direct_to_page">
				SAFETY
			</DIV></A><A href="https://igem.org/2017_Judging_Form?team=Florida_Atlantic"><DIV class="menu_button direct_to_page">
				JUDGING FORM
			</DIV></A></DIV></DIV><DIV class="igem_2017_content_wrapper"><H1>Florida_Atlantic</H1><DIV class="column full_size"><DIV class="column full_size"><H3 style=" font-size:24px ; ">Silver Human Practices</H3><DIV align="justify"><FORM><FIELDSET><P style=" font-size:18px ; ">
Counterfeit and substandard medicines are a growing problem in both the developed and
developing world. All medicines—from antimalarials to cholesterol medication—can be
counterfeited, and as the fake drugs become more convincing, the danger of trained professionals
dispensing substandard medications increases 1 . These counterfeit drugs pose a risk not only to
the patients that receive ineffective and often dangerous fake drugs, but also to the public at large
as diluted and subpar quality medications increase the risk of drug resistance.
In Africa, one of the most commonly faked drugs is the antimalarial artemisinin 2 . Because there
are fewer safeguards against counterfeit medicines, and because it can be difficult to find
legitimate sources of artemisinin, determining the authenticity of artemisinin samples is often of
paramount importance. Devices already exist that can test artemisinin samples to determine if
they are counterfeit, but these devices often require either sophisticated laboratory equipment or
training, which can be difficult to access in the field. Furthermore, no device currently exists that
can both sensitively and specifically determine if a sample of artemisinin is authentic. Because of
the import of developing a device that can be used to generate reliable results in the field, our
team has decided to develop a system that can be used to create a biosensor in a relatively short
period of time and be used with minimal training.
In addition to the work that our team has done in researching the threat of counterfeit medicines,
one of our advisors has extensive knowledge of the danger fake drugs can pose: Dr. Esiobu has
done research into the state of counterfeit drugs around the globe in conjunction with the State
Department. Under her advisement, our team has focused on the most commonly faked drug in
Africa as a test of our system, but a similar approach can be applied to other drugs commonly
faked in Europe or the Americas such as antipsychotics and cholesterol blockers.
___________________________________________________________________________________________________

1 MBA, J. T. (2014, June 25). The Health and Economic Effects of Counterfeit Drugs. Retrieved October 01, 2017,
from http://www.ahdbonline.com/issues/2014/june-2014- vol-7- no-4/1756- the-health- and-economic- effects-of-
counterfeit-drugs
2 Nayyar, G. M., Breman, J. G., Newton, P. N., &amp; Herrington, J. (2012). Poor-quality antimalarial drugs in southeast
Asia and sub-Saharan Africa. The Lancet Infectious Diseases, 12(6), 488-496. doi:10.1016/s1473-3099(12)70064- 6
</P></FIELDSET></FORM></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>